|
|
|
|
||
Re: Bioworld: Enyo enters hep B fray with $24M for cccDNA inhibitor"One-trick pony"?? ABUS is a lot of things (slow, aging, quiet, etc), but "one-trick" is not one of them. I understand cash burn, thanks. My $2.90s "must be a bottom" was tongue in cheek. Also, PLK is expected in 1H16. |
return to message board, top of board |